SARS-CoV-2 specific antibody levels after a third dose of inactivated vaccine among 91 medical staff in Chengdu
China Tropical Medicine
; 22(4):311-314, 2022.
Article
in Chinese
| GIM | ID: covidwho-1903925
ABSTRACT
Objective:
To analysis the production of SARS-CoV-2 antibody among medical staff in Public Health Clinical Center of Chengdu 1 month after a third dose of inactivated vaccine (booster shot), and to compare the SARS-CoV-2 antibody among COVID-19 patients after immunization, in order to analyze the effect of the booster shot.
308067-58-5; antibodies; human diseases; immunization; viral diseases; coronavirus disease 2019; public health; IgG; immune response; disease prevention; pandemics; risk factors; patients; inactivated vaccines; infectious diseases; reinfection; risk reduction; vaccines; immune sensitization; man; Severe acute respiratory syndrome coronavirus 2; China; Sichuan; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; South Western China; SARS-CoV-2; viral infections; People's Republic of China; immunity reactions; immunological reactions; killed vaccines; communicable diseases
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Topics:
Vaccines
Language:
Chinese
Journal:
China Tropical Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS